Premera Joins Takeda Antitrust Litigation Over IBS Drug
Premera Blue Cross on Friday joined litigation accusing Takeda Pharmaceutical Co. of breaking antitrust law by cutting a pay-for-delay deal to keep generic versions of its anti-constipation drug Amitiza off the...To view the full article, register now.
Already a subscriber? Click here to view full article